Congress Proposes New Rules to Help Patients Skip Insurance "Step Therapy" for Medications
The Safe Step Act is currently sitting in the House Committee on Education and Workforce where it has not seen any action since September 2025. Because no progress has been made in nine months, the bill is considered stalled. A similar bill in the Senate is also not moving forward.
Companion bill: Congress Proposes New Rules to Help Patients Skip Insurance 'Fail-First' Drug Requirements →No action since September 2025
This bill’s path across every version that has carried it.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small business owners who offer group health plans to their employees would need to ensure their plans comply with the new step therapy exception requirements. This could slightly increase administrative costs or premiums, but would also benefit them personally and their employees by ensuring faster access to needed medications. The net effect depends on the size of the business and the specifics of their health plan.
Referred to the House Committee on Education and Workforce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
In September 2025, members of the U.S. House and Senate reintroduced the Safe Step Act, requiring group health insurance plans to offer a timely exceptions process for 'fail-first' protocols. The bill aims to protect patients from delays in treatment that can worsen chronic conditions.
The Safe Step Act, a bipartisan federal bill establishing guardrails for step therapy, represents a potential turning point for clinicians and patients. By codifying timely exception processes and promoting transparency, the legislation aims to align insurer protocols with clinical judgment.
An oncologist highlights how step therapy enforced by PBMs prevents timely access to essential medicines. The article discusses the reintroduction of the Safe Step Act on Sept. 19, 2025, as a critical measure to allow exceptions when alternative treatments could cause harm or delay care.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Safe Step Act
Analysis generated by AI. Always verify with official sources.